Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Radiol Phys Technol ; 2024 May 10.
Article in English | MEDLINE | ID: mdl-38730134

ABSTRACT

Non-alcoholic fatty liver disease (NAFLD) and its advanced stage, non-alcoholic steatohepatitis (NASH), have become increasingly prevalent owing to the rise in metabolic syndromes. Accurate assessment of hepatic fat deposition and inflammation is crucial for diagnosing and managing NAFLD/NASH. We investigated the influence of Gd-EOB-DTPA, (EOB) on proton-density fat fraction (PDFF) measurements using chemical shift-encoded magnetic resonance imaging (CSE-MRI) at 3-T. In total, 431 patients who underwent EOB contrast-enhanced MRI were included. PDFF measurements were obtained from pre- and post-contrast CSE-MRI. Linear regression and Bland-Altman analyses were performed to assess the correlation and agreement between pre- and post-EOB PDFF measurements. Relative enhancement (RE) of the liver was calculated as an EOB uptake index. There was a significant decrease in PDFF following EOB administration compared with the pre-contrast values (P < 0.0001), which was observed across all PDFF ranges (< 10% and ≥ 10%). Linear regression analysis revealed high correlation between pre- and post-EOB PDFF measurements. Bland-Altman analysis indicated a small bias between pre- and post-EOB PDFF values. Subgroup analysis based on RE showed a significant difference in ΔPDFF between patients with high RE (> 120%) and those with lower RE levels. EOB administration resulted in a slight decrease in PDFF measurements obtained using CSE-MRI at 3-T. We were able to generalize and clarify that the PDFF of the liver on 3D CSE-MRI at 3-T was slightly decreased after EOB administration as we used a larger group of patients compared to previous studies.

2.
Radiol Phys Technol ; 2024 May 24.
Article in English | MEDLINE | ID: mdl-38782839

ABSTRACT

The purpose of the study was to investigate the relationship between diffusion tensor imaging (DTI) and the clinical classification of cubital tunnel syndrome (CuTS). Ten patients with CuTS (7 men and 3 women; mean age: 52.7 years) and 5 patients without ulnar neuropathy (2 men and 3 women; mean age: 38.0 years) were enrolled in this retrospective study. Fifteen patients were clinically classified into three groups: "Normal", "1 and 2A", and "2B and 3" by an orthopedic surgeon using the modified McGowan stages. DTI was acquired using a 3.0-T MRI. Fractional anisotropy (FA) of the ulnar nerve was measured in slices covering 20 mm proximal to 20 mm distal to ulnar sulcus. Median FA values in each group were compared by Kruskal-Wallis and Steel-Dwass test (P < 0.05). Five patients with CuTS were classified as "1 and 2A" and five patients as "2B and 3". The FA values, proximal 12 mm to the ulnar sulcus were 0.486 ± 0.117, 0.425 ± 0.166 and 0.298 ± 0.0386 in the "Normal", "1 and 2A" and "2B and 3" groups, respectively. The FA values of patients classified as "Normal" were significantly higher than those classified as "2B and 3" (P = 0.0326 in Steel-Dwass test). FA proximal to the ulnar sulcus might be associated to the modified McGowan stages for the clinical classification of CuTS.

3.
Mitochondrion ; 48: 11-15, 2019 09.
Article in English | MEDLINE | ID: mdl-30738201

ABSTRACT

Biomarkers and two clinical rating scales-the Japanese mitochondrial disease-rating scale (JMDRS) and Newcastle mitochondrial disease adult scale (NMDAS)-are clinically used when treating patients with mitochondrial disease. We explored the biomarker(s) and clinical rating scale(s) that are appropriate in preparing the protocol for a future clinical trial of sodium pyruvate (SP) therapy. A 48-week, prospective, single-centre, exploratory, clinical study enrolled 11 Japanese adult patients with genetically, biochemically, and clinically confirmed mitochondrial disease; they had intractable lactic acidosis and received SP (0.5 g/kg t.i.d. PO). Plasma concentrations of lactate and pyruvate, lateral ventricular levels of lactate, and serum concentrations of growth differentiation factor 15 (GDF15) and fibroblast growth factor 21 were measured at baseline and at weeks 12 and 48 of SP therapy. At week 48, plasma lactate (P = .004), the lactate/pyruvate ratio (P = .012), serum GDF15 (P = .020), and lateral ventricular lactate (P = .038) decreased significantly from the baseline values; the JMDRS and NMDAS scores did not decrease significantly, although the NMDAS overall score showed a strong tendency (P = .059). Two patients with end-stage MELAS at baseline died during SP therapy. The present study showed significant decreases in plasma and lateral ventricular lactate, the L/P ratio, and serum GDF15. Therefore, the protocol for a future clinical study of SP therapy in this patient population needs to include plasma and lateral ventricular lactate, the L/P ratio, and serum GDF15 as diagnostic indicators, and exclude patients with end-stage mitochondrial disease.


Subject(s)
Biomarkers/metabolism , Mitochondria/drug effects , Mitochondrial Diseases/drug therapy , Mitochondrial Diseases/metabolism , Pyruvic Acid/pharmacology , Sodium/physiology , Acidosis, Lactic/drug therapy , Acidosis, Lactic/metabolism , Adolescent , Adult , Female , Fibroblast Growth Factors/metabolism , Growth Differentiation Factor 15/metabolism , Humans , Lactic Acid/metabolism , MELAS Syndrome/drug therapy , MELAS Syndrome/metabolism , Male , Middle Aged , Mitochondria/metabolism , Prospective Studies , Young Adult
4.
PLoS One ; 13(11): e0206856, 2018.
Article in English | MEDLINE | ID: mdl-30475826

ABSTRACT

Electrocardiogram (ECG) has been widely used for assessment of right ventricular (RV) hypertrophy (RVH) in patients with pulmonary hypertension (PH). However, it still remains unclear which ECG criteria of RVH are useful to predict for the severity of PH. The aim of our study was to examine the utility of ECG findings of RVH in assessment of PH. A total of 53 patients (42 women, mean age; 57.6 ± 16.4 years) with pre-capillary PH, who were diagnosed by right heart catheterization, underwent blood sampling, ECG, and cardiac magnetic resonance within a week before the right heart catheterization. We assessed the traditional ECG criteria of RVH in PH patients, and compared to age- and gender-matched control subjects without PH confirmed by 2-dimensional echocardiography (n = 42, mean age 55.3 ± 15.9 years). We also analyzed the clinical variables associated with ECG findings in patients with PH. Mean pulmonary arterial pressure (mPAP), cardiac index, and pulmonary vascular resistance (PVR) in PH patients were 35.3 ± 11.9 mmHg, 2.82 (2.09-3.45) L/min/m2, and 576 ± 376 dyne·sec·cm-5, respectively. The prevalence of right axis deviation (43.4%), R:S ratio V1 > 1 (32.1%), and RV1+SV5/6 > 10.5 mm (69.8%) in PH patients was greater than those in control subjects (p < 0.001). In univariate analysis, mPAP, PVR, RV wall thickness, RV mass index, RV volume, and RV ejection fraction (EF) (inversely) were significantly correlated with the amplitude of RV1+SV5/6. Multiple regression analysis revealed that mPAP and RVEF (inversely) were independently associated with the amplitude of RV1+SV5/6 (R2 = 0.282). Also, we performed the survival analysis among pre-capillary PH patients. During a mean follow-up of 3.7 years, patients with ≥ 16.4 mm of RV1+SV5/6 had worse prognosis than those with < 16.4 mm (Log rank p = 0.015). In conclusion, the amplitude of SV1+RV5/6 could be the most useful factor reflected for RV remodeling, hemodynamics and survival in patients with pre-capillary PH.


Subject(s)
Echocardiography/methods , Electrocardiography/methods , Hypertension, Pulmonary/complications , Hypertrophy, Right Ventricular/diagnosis , Adult , Aged , Cardiac Catheterization , Case-Control Studies , Female , Follow-Up Studies , Heart Ventricles/diagnostic imaging , Heart Ventricles/physiopathology , Hemodynamics/physiology , Humans , Hypertension, Pulmonary/mortality , Hypertension, Pulmonary/physiopathology , Hypertrophy, Right Ventricular/etiology , Hypertrophy, Right Ventricular/mortality , Hypertrophy, Right Ventricular/physiopathology , Male , Middle Aged , Predictive Value of Tests , Prognosis , Severity of Illness Index , Survival Analysis , Vascular Resistance/physiology , Ventricular Function, Right/physiology , Ventricular Remodeling/physiology
5.
Nihon Hoshasen Gijutsu Gakkai Zasshi ; 69(11): 1266-73, 2013 Nov.
Article in Japanese | MEDLINE | ID: mdl-24256650

ABSTRACT

Stereotactic radiosurgery (SRS) and radiotherapy (SRT) are intricate techniques that deliver a highly precise radiation dose to a localized target, usually a tumor. At our hospital, we perform SRS and SRT on brain tumors using a linear accelerator (linac) mounted with an external micro multi-leaf system. The Task Group TG-142 Report by the American Association of Physicists in Medicine recommends the coincidence of the radiation and mechanical isocenter to be within ±1 mm. The Winston-Lutz test is commonly used to verify the linac isocenter position: it has the advantages of being a simple method that uses a film or electronic portal imaging device (EPID). However, the film method requires a higher radiation dose, which makes it more time-consuming than the EPID method, and the results are highly dependent on the skills of the observer. The EPID method has certain advantages over the film method, but it has low resolution and can only be used for a few combinations of gantry and couch angles. This prompted us to develop an in-house-designed radiation receptor system based on digital radiography, using a photostimulable storage phosphor and automated analysis algorithm for Winston-Lutz test images using a template-matching technique based on cross-correlation coefficients. Our proposed method shows a maximum average absolute error of 0.222 mm (less than 2 pixels) for 0.5 mm and 1.0 mm displacement from the isocenter toward the inline and crossline directions. Our proposed method is thus potentially useful for verifying the Linac isocenter position with a small error and good reproducibility, as demonstrated by improved accuracy of evaluation.


Subject(s)
Image Processing, Computer-Assisted/methods , Radiographic Image Enhancement/methods , Radiosurgery/methods , Radiotherapy, Image-Guided/methods , Algorithms , Brain Neoplasms/radiotherapy , Humans , Particle Accelerators
6.
J Radiat Res ; 53(5): 742-52, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22843357

ABSTRACT

Digital pelvic radiographs are used to identify the locations of implanted iodine-125 seeds and their numbers after insertion. However, it is difficult and laborious to visually identify and count all implanted seeds on the pelvic radiographs within a short time. Therefore, our purpose in this research was to develop an automated method for estimation of the number of implanted seeds based on two-view analysis of pelvic radiographs. First, the images of the seed candidates on the pelvic image were enhanced using a difference of Gaussian filter, and were identified by binarizing the enhanced image with a threshold value determined by multiple-gray level thresholding. Second, a simple rule-base method using ten image features was applied for false positive removal. Third, the candidates for the likely number of a multiply overlapping seed region, which may include one or more seeds, were estimated by a seed area histogram analysis and calculation of the probability of the likely number of overlapping seeds. As a result, the proposed method detected 99.9% of implanted seeds with 0.71 false positives per image on average in a test for training cases, and 99.2% with 0.32 false positives in a validation test. Moreover, the number of implanted seeds was estimated correctly at an overall recognition rate of 100% in the validation test using the proposed method. Therefore, the verification time for the number of implanted seeds could be reduced by the provision of several candidates for the likely number of seeds.


Subject(s)
Brachytherapy/statistics & numerical data , Prostatic Neoplasms/radiotherapy , Aged , Automation , Humans , Iodine Radioisotopes/administration & dosage , Male , Middle Aged , Pelvis/diagnostic imaging , Radiographic Image Enhancement/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...